Related references
Note: Only part of the references are listed.miRBase: from microRNA sequences to function
Ana Kozomara et al.
NUCLEIC ACIDS RESEARCH (2019)
MiR-503 suppresses hypoxia-induced proliferation, migration and angiogenesis of endothelial progenitor cells by targeting Apelin
Ya Wen et al.
PEPTIDES (2018)
Quaking Inhibits Doxorubicin-Mediated Cardiotoxicity Through Regulation of Cardiac Circular RNA Expression
Shashi Kumar Gupta et al.
CIRCULATION RESEARCH (2018)
Circulating MicroRNA-122 Is Associated With the Risk of New-Onset Metabolic Syndrome and Type 2 Diabetes
Peter Willeit et al.
DIABETES (2017)
Long-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology: A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Paclitaxel and Trastuzumab in Patients With Node-Positive Breast Cancer With Tumors Overexpressing Human Epidermal Growth Factor Receptor 2
Patricia A. Ganz et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
The long noncoding RNA Wisper controls cardiac fibrosis and remodeling
Rudi Micheletti et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Clinical and subclinical cardiac late effects in pediatric Hodgkin's lymphoma survivors
Carlo Materazzo et al.
TUMORI JOURNAL (2017)
Clinical and subclinical cardiac late effects in pediatric Hodgkin's lymphoma survivors
Carlo Materazzo et al.
TUMORI JOURNAL (2017)
Inhibition of MicroRNA-146a and Overexpression of Its Target Dihydrolipoyl Succinyltransferase Protect Against Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction
Ward A. Heggermont et al.
CIRCULATION (2017)
Inhibition of the Cardiac Fibroblast- Enriched lncRNA Meg3 Prevents Cardiac Fibrosis and Diastolic Dysfunction
Maria-Teresa Piccoli et al.
CIRCULATION RESEARCH (2017)
Paradoxical Suppression of Atherosclerosis in the Absence of microRNA-146a
Henry S. Cheng et al.
CIRCULATION RESEARCH (2017)
MicroRNA-Based Therapy of GATA 2-Deficient Vascular Disease
Dorothee Hartmann et al.
CIRCULATION (2016)
Liver microRNAs: potential mediators and biomarkers for metabolic and cardiovascular disease?
Peter Willeit et al.
EUROPEAN HEART JOURNAL (2016)
NON-CODING RNAs IN DEVELOPMENT AND DISEASE: BACKGROUND, MECHANISMS, AND THERAPEUTIC APPROACHES
Julia Beermann et al.
PHYSIOLOGICAL REVIEWS (2016)
A peptide encoded by a transcript annotated as long noncoding RNA enhances SERCA activity in muscle
Benjamin R. Nelson et al.
SCIENCE (2016)
Long noncoding RNA Chast promotes cardiac remodeling
Janika Viereck et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Profiling and Validation of the Circular RNA Repertoire in Adult Murine Hearts
Tobias Jakobi et al.
GENOMICS PROTEOMICS & BIOINFORMATICS (2016)
A Micropeptide Encoded by a Putative Long Noncoding RNA Regulates Muscle Performance
Douglas M. Anderson et al.
CELL (2015)
Identification and Characterization of Hypoxia-Regulated Endothelial Circular RNA
Jes-Niels Boeckel et al.
CIRCULATION RESEARCH (2015)
CARMEN, a human super enhancer-associated long noncoding RNA controlling cardiac specification, differentiation and homeostasis
Samir Ounzain et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2015)
Development of Long Noncoding RNA-Based Strategies to Modulate Tissue Vascularization
Jan Fiedler et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
The Xist lncRNA interacts directly with SHARP to silence transcription through HDAC3
Colleen A. McHugh et al.
NATURE (2015)
In Vitro Antiviral Activity and Preclinical and Clinical Resistance Profile of Miravirsen, a Novel Anti-Hepatitis C Virus Therapeutic Targeting the Human Factor miR-122
Soren Ottosen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Identification and Characterization of Circular RNAs As a New Class of Putative Biomarkers in Human Blood
Sebastian Memczak et al.
PLOS ONE (2015)
Circulating Long Noncoding RNA, LIPCAR, Predicts Survival in Patients With Heart Failure
Regalla Kumarswamy et al.
CIRCULATION RESEARCH (2014)
Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy
Claudia Bang et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
A long noncoding RNA protects the heart from pathological hypertrophy
Pei Han et al.
NATURE (2014)
miRBase: annotating high confidence microRNAs using deep sequencing data
Ana Kozomara et al.
NUCLEIC ACIDS RESEARCH (2014)
MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor angiogenesis and growth
Bisheng Zhou et al.
CANCER LETTERS (2013)
Genome-wide survey by ChIP-seq reveals YY1 regulation of lincRNAs in skeletal myogenesis
Leina Lu et al.
EMBO JOURNAL (2013)
MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy
Julie Halkein et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
eRNAs Promote Transcription by Establishing Chromatin Accessibility at Defined Genomic Loci
Kambiz Mousavi et al.
MOLECULAR CELL (2013)
Activating RNAs associate with Mediator to enhance chromatin architecture and transcription
Fan Lai et al.
NATURE (2013)
Natural RNA circles function as efficient microRNA sponges
Thomas B. Hansen et al.
NATURE (2013)
Circular RNAs are a large class of animal RNAs with regulatory potency
Sebastian Memczak et al.
NATURE (2013)
Treatment of HCV Infection by Targeting MicroRNA
Harry L. A. Janssen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Inhibition of miR-15 Protects Against Cardiac Ischemic Injury
Thomas G. Hullinger et al.
CIRCULATION RESEARCH (2012)
Long noncoding RNAs are rarely translated in two human cell lines
Balazs Banfai et al.
GENOME RESEARCH (2012)
The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression
Thomas Derrien et al.
GENOME RESEARCH (2012)
Discovering the first microRNA-targeted drug
Morten Lindow et al.
JOURNAL OF CELL BIOLOGY (2012)
Prospective Study on Circulating MicroRNAs and Risk of Myocardial Infarction
Anna Zampetaki et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Functional screening identifies miRNAs inducing cardiac regeneration
Ana Eulalio et al.
NATURE (2012)
Landscape of transcription in human cells
Sarah Djebali et al.
NATURE (2012)
The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy
Ahmet Ucar et al.
NATURE COMMUNICATIONS (2012)
MicroRNA-24 Regulates Vascularity After Myocardial Infarction
Jan Fiedler et al.
CIRCULATION (2011)
Therapeutic Inhibition of miR-208a Improves Cardiac Function and Survival During Heart Failure
Rusty L. Montgomery et al.
CIRCULATION (2011)
Members of the microRNA-17-92 cluster exhibit a cell-intrinsic antiangiogenic function in endothelial cells
Carmen Doebele et al.
BLOOD (2010)
Long Noncoding RNAs with Enhancer-like Function in Human Cells
Ulf Andersson Orom et al.
CELL (2010)
Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes
Anna Zampetaki et al.
CIRCULATION RESEARCH (2010)
Widespread transcription at neuronal activity-regulated enhancers
Tae-Kyung Kim et al.
NATURE (2010)
Cardiotoxicity of anticancer treatments: what the cardiologist needs to know
Michael S. Ewer et al.
NATURE REVIEWS CARDIOLOGY (2010)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
Most mammalian mRNAs are conserved targets of microRNAs
Robin C. Friedman et al.
GENOME RESEARCH (2009)
MENε/β noncoding RNAs are essential for structural integrity of nuclear paraspeckles
Yasnory T. F. Sasaki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
RNA polymerase II activity is located on the surface of protein-rich transcription factories
Christopher H. Eskiw et al.
JOURNAL OF CELL SCIENCE (2008)
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
Thomas Thum et al.
NATURE (2008)
Anthracycline associated cardiotoxicity in survivors of childhood cancer
Steven E. Lipshultz et al.
HEART (2008)
The imprinted H19 noncoding RNA is a primary microRNA precursor
Xuezhong Cai et al.
RNA (2007)
The microRNA Registry
S Griffiths-Jones
NUCLEIC ACIDS RESEARCH (2004)
Congestive heart failure in patients treated with doxorubicin - A retrospective analysis of three trials
SM Swain et al.
CANCER (2003)